Health-related quality of life assessment in multiple sclerosis

2019 ◽  
pp. 94-113
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Life Assessment ◽  
Health Related Quality ◽  
Quality Of Life Assessment ◽  
Related Quality ◽  
Health Related

Health-related quality of life assessment in multiple sclerosis

2011 ◽  
pp. 79-90 ◽  
Author(s):  
Deborah M. Miller ◽  
Michael W. Kattan ◽  
Alex Z. Fu
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Life Assessment ◽  
Health Related Quality ◽  
Quality Of Life Assessment ◽  
Related Quality ◽  
Health Related

Long-Term Effectiveness of Fingolimod for Multiple Sclerosis in a Real-World Clinical Setting

2021 ◽  
pp. 1-6
Author(s):  
Cihat Uzunköprü ◽  
Yesim Beckmann ◽  
Sabiha Türe
Keyword(s):  
Quality Of Life ◽  
Multiple Sclerosis ◽  
Real Life ◽  
Life Assessment ◽  
Health Related Quality ◽  
Serious Adverse Events ◽  
Related Quality ◽  
Health Related

<b><i>Introduction:</i></b> The primary aim of the present study was to evaluate the long-term efficacy of fingolimod in patients with multiple sclerosis (MS); secondary aims were to describe the safety of fingolimod with the evaluation of treatment satisfaction and impact on the quality of life in real life. <b><i>Methods:</i></b> We collected clinical, demographical, neuroradiological, and treatment data, including pre- and posttreatment status health-related quality of life from 286 MS patients consecutively treated with fingolimod. Clinical assessment was based on the Expanded Disability Status Scale (EDSS), and quality of life assessment was performed with MS-related quality of life inventory (MSQOLI). The data were recorded at baseline and every 6 months for 2 years. <b><i>Results:</i></b> One hundred and fourteen males and 172 females were enrolled. The annualized relapse rate and EDSS showed a statistically significant reduction during the observation period (<i>p</i> &#x3c; 0.001). The patients also demonstrated substantial improvements in magnetic resonance imaging (MRI) outcomes (<i>p</i> &#x3c; 0.001). Health-related quality of life scores improved significantly between baseline and 24-month visit (<i>p</i> &#x3c; 0.001). No serious adverse events occurred. <b><i>Conclusion:</i></b> In our cohort, fingolimod treatment was associated with reduced relapse, MRI activity, and improved EDSS and MSQOLI scores. Additionally, fingolimod has been able to maintain its effectiveness over a considerable long period of treatment.

Accuracy of health-related quality of life assessment: What is the benefit of incorporating patients' preferences for domain functioning?

2001 ◽  
Vol 20 (2) ◽  
pp. 136-140 ◽  
Author(s):  
Kristina G. Gorbatenko-Roth ◽  
Irwin P. Levin ◽  
Elizabeth M. Altamaier ◽  
Bradley N. Doebbeling
Keyword(s):  
Quality Of Life ◽  
Life Assessment ◽  
Health Related Quality ◽  
Quality Of Life Assessment ◽  
Related Quality ◽  
Health Related

scholarly journals OC-0320: Pre-radiotherapy health related quality of life assessment associates with survival in lung cancer patients

2015 ◽  
Vol 115 ◽  
pp. S160
Author(s):  
S. Perez-Luque ◽  
J. Cacicedo ◽  
L. Delgado Arroniz ◽  
J.M. Praena-Fernandez ◽  
E. Montero ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Cancer Patients ◽  
Life Assessment ◽  
Health Related Quality ◽  
Quality Of Life Assessment ◽  
Lung Cancer Patients ◽  
Related Quality ◽  
Health Related
Sign in / Sign up

Export Citation Format

Share Document